Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine spray for post-ERCP pancreatitis prevention
NCT02839356Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jul 2016
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of epinephrine in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by The First Affiliated Hospital of USTC. Status: unknown.
02
Drugs
epinephrine
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT02839356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02839356.